← All organizations

Equilab International

For profitWebsite ↗

Also known as: Equilab International | PT Equilab International | PT. Equilab International

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 8, 2023

Timeline

2000s

Nov 1, 2002
Equilab International— Founded

Drugs by trial phase (13 distinct, 13 trials)

Phase 2 (1 own, 0 via acquisition)

proliverenol

Phase 1 (1 own, 0 via acquisition)

rivaroxaban

Other trials (11 own, 0 via acquisition)

Recent trials (15)

NCT06558058CollaboratorPhase 1Jun 8, 2023
NCT06127225CollaboratorPhase 2Apr 28, 2023
NCT06127212CollaboratorN/AMar 8, 2023
NCT06127212Overall official - principal investigatorN/AMar 8, 2023
NCT05373303CollaboratorN/ANov 7, 2019
NCT05335720CollaboratorN/AJul 19, 2019
NCT03422575CollaboratorN/ADec 31, 2015
NCT03422575Study directorN/ADec 31, 2015
NCT02660060Overall official - principal investigatorN/AMay 1, 2015
NCT02233777Overall official - principal investigatorN/AJun 1, 2014
NCT02518451Study directorN/AJun 1, 2013
NCT01378585Overall official - principal investigatorN/AMay 1, 2011
NCT01677247Overall official - principal investigatorN/AFeb 1, 2011
NCT01677260Overall official - principal investigatorN/AOct 1, 2009
NCT01682577Overall official - principal investigatorN/ASep 1, 2008

Details

Founded: Jakarta, ID Nov 1, 2002
Last known activity: Jun 8, 2023

Notes

CRO